KawaguchiY., OtaK., NakagawaS., FujinagaT., FujimiS.Continuous ambulatory peritoneal dialysis: one year's experience of cooperative study in Japan. In: GahlG.M., KesselM., NolphK.D., eds. Advances in Peritoneal Dialysis: Proceedings of the Second International Symposium on Peritoneal Dialysis Berlin (-West), June 16-19, 1981.Amsterdam: Excerpta Medica; 1981: 233–5.
2.
Japanese Society for Dialysis Therapy.An overview of regular dialysis treatment in Japan as of 31 December 2003.Ther Apher Dial2005; 9: 431–58.
3.
MoellerS., GiobergeS., BrownG.ESRD patients in 2001: global overview of patients, treatment modalities and development trends.Nephrol Dial Transplant2002; 17: 2071–6.
4.
KawaguchiY., HasegawaT., NakayamaM., KuboH., ShigematuT.Issues affecting the longevity of the continuous peritoneal dialysis therapy.Kidney Int Suppl1997; 62: S105–7.
5.
KawaguchiY., IshizakiT., ImadaA., OohiraS., KuriyamaS., NakamotoH., Study Group for Withdrawal from PD in Japan. Searching for the reasons for drop-out from peritoneal dialysis: a nationwide survey in Japan.Perit Dial Int2003; 23(Suppl 2): S175–7.
6.
ImadaA., KawaguchiY., KumanoK., NomotoY., for the CAPD-Related Peritonitis Study Group in Japan. A multicenter study of CAPD-related peritonitis in Japan [in Japanese].J Jpn Soc Dial Ther2001; 34: 1157–62 [abstract in English].
7.
KawanishiH., KawaguchiY., FukuiH., HaraS., ImadaA., KuboH.Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.Am J Kidney Dis2004; 44: 729–37.
NakayamaM., IkedaM., KatohN., YokoyamaK., YamamotoH., KawaguchiY.Is encapsulating peritoneal sclerosis a threatening issue in continuous ambulatory peritoneal dialysis? The Japanese experience.Perit Dial Int2003; 23(Suppl 2): S132–3.
10.
KawanishiH., MoriishiM., KatsutaniS., SakikuboE., TsuchiyaS.Hemodialysis together with peritoneal dialysis is one of the simplest ways to maintain adequacy in continuous ambulatory peritoneal dialysis.Adv Perit Dial1999; 15: 127–31.
NumataM., NakayamaM., HosoyaT., HoffC.M., HolmesC.J., SchallingM.Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients.Clin Nephrol2004; 62: 455–60.
13.
ShioshitaK., MiyazakiM., OzonoY., AbeK., TauraK., HaradaT.Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis.Kidney Int2000; 57: 619–31.
14.
YoshioY., MiyazakiM., AbeK., NishinoT., FurusuA., MizutaY.TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.Kidney Int2004; 66: 1677–85.
15.
OreopoulosD.G.Peritoneal dialysis in the Far East: an awaking giant.Perit Dial Int2004; 24: 528–30.